NCT00562406View on ClinicalTrials.gov

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Macular Edema
Interventions
DRUG

Ranibizumab

intravitreal injection of 0.5 mg ranibizumab after randomisation, at week 4 and 8

PROCEDURE

Laser photocoagulation

laser photocoagulation to the retina at the area of edema

Trial Locations (4)

67063

RABAMES investigational trial site, Ludwigshafen

Unknown

RABAMES investigational trial site, Freiburg im Breisgau

RABAMES investigational trial site, Göttingen

RABAMES investigational trial site, Mainz

All Listed Sponsors
collaborator

Norvartis Pharma, Nuremberg, Germany

UNKNOWN

collaborator

Coordination center for clinical studies, Mainz, Germany

UNKNOWN

lead

Klinikum Ludwigshafen

OTHER

NCT00562406 - Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) | Biotech Hunter | Biotech Hunter